Source comparison
Selank vs Semax for Cognitive Research UK 2026
All peptides discussed in this article are supplied strictly for in vitro and in vivo laboratory research use only (RUO). None are approved for human therapeutic use, and none of the data presented constitute medical advice or clinical guidance. This compariso
This comparison does not assign a generated winner or score.
- All peptides discussed in this article are supplied strictly for in vitro and in vivo laboratory research use only (RUO). None are approved for human therapeutic use, and none of the data presented constitute medical advice or clinical guidance. This comparison is distinct from our Selank vs DSIP post (ID 77483, which covers GABA-A/5-HT2C versus SWS slow-wave sleep peptide biology) and our BPC-157 vs Semax post (ID 77481, which covers gut-derived cytoprotective biology versus ACTH-derived MC4R biology in HPA context). This article is a direct head-to-head comparison: Selank’s GABA-A allosteric potentiation and 5-HT2C agonism as the primary anxiolytic-cognitive mechanism versus Semax’s MC4R-driven BDNF/TrkB hippocampal neuroplasticity as the primary cognitive-HPA mechanism — in learning, memory, and anxiety-cognitive dual models.